BALYASNY ASSET MANAGEMENT L.P. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,802,540
-69.9%
39,000
-67.7%
0.01%
-76.9%
Q4 2022$9,323,012
+422.3%
120,874
+202.2%
0.03%
+420.0%
Q3 2022$1,785,000
-53.4%
40,000
-60.0%
0.01%
-58.3%
Q2 2022$3,830,000
+161.1%
100,000
+124.7%
0.01%
+100.0%
Q3 2021$1,467,000
-71.9%
44,509
-39.3%
0.01%
-84.2%
Q3 2020$5,220,000
+15252.9%
73,268
+421.5%
0.04%
Q1 2018$34,00014,0500.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders